Objective: To determine whether early environmental factors, such as cesarean delivery, breastfeeding, and exposure to smoking or herpes viruses, are associated with neuromyelitis optica (NMO) risk in children.
Results:
Early-life exposures were obtained from 36 pediatric subjects with NMO, 491 with MS, and 224 healthy controls. Daycare (odds ratio [OR] 0.33, 95% confidence interval [CI] 0.14, 0.78; p , 0.01) and breastfeeding (OR 0.42, 95% CI 0.18, 0.99; p 5 0.05) were associated with lower odds of having NMO compared with healthy subjects. Cesarean delivery tended to be associated with 2-fold-higher odds of NMO compared with having MS/clinically isolated syndrome (OR 1.98, 95% CI 0.88, 4.59; p 5 0.12) or with being healthy (OR 1.95, 95% CI 0.81, 4.71; p 5 0.14). Sera and DNA were available for 31 subjects with NMO, 189 with MS, and 94 healthy controls. Epstein-Barr virus, herpes simplex virus 1, cytomegalovirus exposure, and being HLA-DRB1*15 positive were not associated with odds of having NMO compared with healthy subjects.
Conclusions: Exposure to other young children may be an early protective factor against the development of NMO, as previously reported for MS, consistent with the hypothesis that infections contribute to disease risk modification. Unlike MS, pediatric NMO does not appear to be associated with exposures to common herpes viruses. Neurology ® 2014;83:1923-1929 GLOSSARY AQP4 5 aquaporin-4; CI 5 confidence interval; CIS 5 clinically isolated syndrome; CMV 5 cytomegalovirus; EBNA1 5 Epstein Barr nuclear antigen-1; EBV 5 Epstein-Barr virus; HSV-1 5 herpes simplex virus 1; IgG 5 immunoglobulin G; MS 5 multiple sclerosis; NMO 5 neuromyelitis optica; OR 5 odds ratio; VCA 5 viral capsid antigen.
Neuromyelitis optica (NMO) is characterized by optic neuritis, brainstem deficits, and transverse myelitis and is associated with aquaporin-4 (AQP4) antibodies. 1 Adult studies suggest that genetic susceptibility to NMO is likely present, but most compatible with a complex disorder with an important component of nongenetic factors. 2, 3 Environmental risk factors for NMO are thus likely critical to disease onset, but these are largely unknown. In children, cases may follow a viral prodrome whereas in adults molecular mimicry involving T-cell responses against a Clostridium species may be important for disease initiation. 4, 5 In Japanese adults, exposure to the organisms Helicobacter pylori or Chlamydophila pneumonia may be associated with AQP4-immunoglobulin G (IgG)-positive NMO. 6 In contrast with NMO, a number of environmental risk factors have been consistently reported for multiple sclerosis (MS) in adults and children. Epstein-Barr virus (EBV) antibody response is associated with increased risk of MS. [7] [8] [9] [10] Early exposure to cytomegalovirus (CMV) may be protective, while HLA-DRB1*15:01 status modifies the association of herpes simplex virus 1 (HSV-1) antibodies with MS. 10, 11 Early-life events such as breastfeeding and exposure to other young children may affect MS risk as well. [12] [13] [14] [15] The effect of these factors on NMO risk is not known.
The study of environmental factors in pediatric patients offers many advantages. Less bias in the recollection of early childhood events may occur and data are collected during the time of primary exposure to many factors including herpes virus infections. We sought to determine whether early-life events subjects with NMO, 491 with MS, and 224 healthy controls (table 1) . Pediatric subjects with NMO were younger at onset than subjects with MS/CIS (p , 0.01). There were also racial differences across the diagnostic groups (p , 0.01) with more African Americans in the NMO group. NMO cases had 58% frequency of positive results for AQP4-IgG. While AQP4-IgG-positive and -negative NMO cases were combined for the primary analyses, we did observe some demographic differences, with AQP4-IgG-positive individuals more likely to be female and of nonwhite descent than AQP4-IgG-negative subjects with NMO ( DISCUSSION In this study of early environmental risk factors of NMO, we have demonstrated that breastfeeding and daycare exposure may be protective. The immune benefits of breastfeeding are well recognized. For autoimmune diseases, the benefit may be related to transfer of maternal antigens and immune cells, resulting in improved immunity or tolerance. 22 Protective effects have been demonstrated for atopic allergies, type 1 diabetes, Crohn disease, MS, and rheumatoid arthritis, although some of these findings remain controversial. 13, [22] [23] [24] [25] [26] [27] [28] [29] [30] Early exposure to other children has been consistently associated with decreased MS risk, implicating that viral infections early in life are protective. 15, 31 Daycare provides one of the largest exposures to pathogens for young children. Our findings suggest that attending daycare also likely protects against the development of NMO. We did not find that exposure to younger or older siblings increased the odds of NMO, but the subjects we evaluated had few siblings and the overall number of included patients with NMO was small, such that an association cannot be excluded.
In MS, while early viral exposures may be protective, EBV infection and, in particular, late EBV infection, resulting in mononucleosis, have been strongly associated with MS risk. 7, 32 We found no association of EBV exposure as measured by standard VCA or EBNA1 ELISA and NMO compared with healthy subjects. This was despite the older age of blood draw in the subjects with NMO. These data suggest that EBV infection likely does not increase risk of NMO.
Whereas passive smoking has been implicated in increasing risk of some autoimmune diseases including MS, we did not find evidence of an association of early exposure to cigarette smoke with odds of NMO, although our sample size of subjects with NMO was limited. 33, 34 We found delivery by cesarean section tended to be associated with a 2-foldgreater odds of NMO, compared with either healthy controls or subjects with MS. Even though the observation did not reach statistical significance, the magnitude of the point estimate was the same for analyses with both control groups and warrants further investigation in a larger study. The significance of a nonvaginal birth and autoimmune disease has been previously postulated to relate to early differences in infant gut flora. 35, 36 Similar to recent findings in adults, we observed demographic differences in AQP4-IgG-positive and -negative subjects with NMO. 37, 38 Subjects testing positive were predominantly female and nonwhite whereas the sex ratio in AQP4-IgG-negative subjects with NMO neared 1 and the majority were of white ancestry. Because of limited number of NMO cases, we were not able to further stratify our multivariable analyses by AQP4-IgG status, but this would be of interest in future, larger studies of NMO risk factors.
The strengths of our study include the careful case ascertainment and the use of 2 types of controls coming from the same centers. Nevertheless, we acknowledge some limitations of this study. The number of pediatric subjects with NMO was small. The variables most vulnerable to sample-size limitations in our study may be insurance, smoking, and cesarean delivery, because these show plausible patterns isolated to the NMO group, that if present in a larger sample size may have been significant. Recall bias is of concern in casecontrol studies, but this may be less of a limitation in the pediatric setting where the early environmental risk factor data are ascertained from parents and at time points closer to exposure than in adult studies. Recall bias is also likely to be similar and less influential in comparison of 2 disease states-MS and NMO. Furthermore, the older age and longer disease duration at serum collection for the NMO group means that viral exposures for the NMO group at time of onset may have been different compared with time of serum testing, although analyses were adjusted for both. However, the older age could not explain a lower frequency of seropositivity for viruses studied.
Pathologic and biological evidence now demonstrate that NMO and MS are separate entities. Our study suggests that risk factors for both disorders may also differ. Larger prospective case-control studies will further identify genetic and environmental risk factors specific to NMO. These may in turn help define more in-depth disease processes at play.
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